Page last updated: 2024-11-05

tolbutamide and Cancer of Duodenum

tolbutamide has been researched along with Cancer of Duodenum in 1 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Woltering, EA1
O'Dorisio, TM1
Mekhjian, HS1
Ellison, EC1
Dyben, T1
Howe, BA1
Tuttle, SE1
Minton, JP1

Other Studies

1 other study available for tolbutamide and Cancer of Duodenum

ArticleYear
The response of a non-functional VIP- and somatostatin-containing tumour to tolbutamide in vitro.
    Scandinavian journal of gastroenterology. Supplement, 1986, Volume: 119

    Topics: Aged; Duodenal Neoplasms; Female; Humans; In Vitro Techniques; Paraneoplastic Endocrine Syndromes; S

1986